417 related articles for article (PubMed ID: 8121069)
1. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A
Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
[TBL] [Abstract][Full Text] [Related]
3. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
4. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA].
Torizuka K; Ishibashi A; Ikekubo K; Yamamoto K; Nishibuchi S
Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of renal function using 99mTc-MAG3: comparison with 123I-OIH and 99mTc-DTPA].
Takayama T; Aburano T; Shuke N; Yokoyama K; Michigishi T; Sun BF; Tonami N; Hisada K; Takabatake T; Ohta H
Kaku Igaku; 1993 Jul; 30(7):753-60. PubMed ID: 8377298
[TBL] [Abstract][Full Text] [Related]
6. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
8. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
[TBL] [Abstract][Full Text] [Related]
9. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
11. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
13. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative analysis of individual renal function using 99mTc-DMSA scintigram--comparison with 131I-OIH renogram].
Komai S; Toyama H; Takeuchi A; Yokoyama K; Koga S
Kaku Igaku; 1995 Apr; 32(4):427-33. PubMed ID: 7776550
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 123I-orthoiodohippurate.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Furudate M
Nucl Med Commun; 1993 Aug; 14(8):644-52. PubMed ID: 8371889
[TBL] [Abstract][Full Text] [Related]
18. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
Stabin M; Taylor A; Eshima D; Wooter W
J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
Shirakawa S; Tamaki N; Torizuka T; Fujita T; Yano S; Tsuchimochi S; Yonekura Y; Konishi J; Terai A
Kaku Igaku; 1994 Aug; 31(8):977-83. PubMed ID: 7933686
[TBL] [Abstract][Full Text] [Related]
20. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats.
Pathuri G; Sahoo K; Awasthi V; Gali H
Nucl Med Commun; 2011 Oct; 32(10):908-12. PubMed ID: 21876402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
